Vineet Jindal

Vineet Jindal, Chief Financial Officer

Vinny is the Chief Financial Officer of Reneo Pharmaceuticals. Vinny brings more than 20 years of experience in investor relations, corporate communications, capital markets, licensing, strategy, and corporate development. Vinny served as the Vice President of Strategy and the Vice President of Corporate Communications and Investor Relations at Reata Pharmaceuticals. In these roles, he oversaw the business development, competitive intelligence, corporate communications, and investor relations functions at Reata, and played a key role in the company’s strategic financings. Prior to his time at Reata, Vinny was the Entrepreneur-In-Residence at the University of Texas, Southwestern, and was the founder of several startup companies, including an investor networking platform and a life sciences business consultancy firm. Previously, he was a Managing Director and Head of Healthcare Equity Research at ThinkEquity and served as the Vice President of Biotechnology Equity Research at Wedbush Morgan Securities. Vinny was also a biotechnology and specialty pharmaceuticals research analyst at Origin Capital Management and Lehman Brothers.

Vinny earned his M.S. in Pharmacology from the Weill Medical College of Cornell University, an M.S. in Endocrinology, and a B.A. in Integrative Biology from the University of California, Berkeley.